Anbio Biotechnology (NNNN) Liabilities and Shareholders Equity (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Liabilities and Shareholders Equity of $30.2 million for Q4 2025, up 59.83% year-over-year from $18.9 million in Q4 2024, and down 100.0% quarter-over-quarter from $27680.6 billion in Q2 2025.
Anbio Biotechnology (NNNN) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $30.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 59.83% year-over-year to $30.2 million; the TTM figure through Dec 2025 stood at $27680.7 billion (changed N/A YoY), while the FY2025 annual figure was $30.2 million, up 59.83% from the prior year.
- Liabilities and Shareholders Equity slipped to $30.2 million in Q4 2025 per NNNN's latest filing, from $27680.6 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $27680.6 billion in Q2 2025 and bottomed at $15.8 million in Q4 2023.
- Historically, Liabilities and Shareholders Equity has averaged $6920.2 billion across 3 years, with a median of $24.6 million in 2024.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity advanced 19.67% — and 2025, when it surged 59.83%.
- Anbio Biotechnology's Liabilities and Shareholders Equity stood at $15.8 million in 2023, then gained by 19.67% to $18.9 million in 2024, then soared by 59.83% to $30.2 million in 2025.
- Business Quant data shows NNNN's Liabilities and Shareholders Equity at $30.2 million in Q4 2025, $27680.6 billion in Q2 2025, and $18.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - | 30.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.24 Mn |
| Jun 30, 2025 | 27,680.59 Bn |
| Dec 31, 2024 | 18.92 Mn |
| Dec 31, 2023 | 15.81 Mn |